Evidence map›Paper›PMID 40391064›Full record

ArticleERJ open research2025

A comprehensive evaluation of murine and human

Camille David, Deborah Brea, Charles Verney, Adeline Cezard, Virginie Vasseur, Benoit Briard, Sandra Khau, Emilie Barsac, Marion Ferreira, Sylvain Marchand-Adam and 2 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Readiness of theFrontiers in toxicology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Camille DavidINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.ORCID https://orcid.org/0009-0006-3625-2842
Deborah BreaINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Charles VerneyINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Adeline CezardINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Virginie VasseurINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Benoit BriardINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.ORCID https://orcid.org/0000-0002-1496-9408
Sandra KhauINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.ORCID https://orcid.org/0009-0004-3348-6569
Emilie BarsacINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Marion FerreiraINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Sylvain Marchand-AdamINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Mustapha Si-TaharINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.
Antoine GuillonINSERM, Centre d'Etude des Pathologies Respiratoires, UMR 1100, Tours, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Alveolar macrophages (AMs) serve as the frontline defence in the lungs; however, comprehensive cell culture models for their study remain limited. Freshly isolated AMs are hindered by restricted quantities (mice) or challenges in accessing donors (humans). Recently, murine fetal liver-derived macrophages cultured with granulocyte-macrophages colony-stimulating factor were proposed as AMs-like macrophage (called MPI). Furthermore, recent technical progress improved the culture and expansion of primary murine AMs. Methods: We examined three distinct Results: We observed that: 1) isolated AMs from mice and humans can be cultured for several days (human) or months (mice) with minor loss of AM-specific surface markers expression over time; 2) MPI is a self-replicative macrophage model that is easy to culture but lacks the typical AM surface expression marker ( Conclusion: Our study provides a comprehensive comparison of

Identifiers

PMID40391064
PMCPMC12086855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.